Health Ahead Comparative Effectiveness Study
Part of paid clinical trials in Boulder, Colorado.
- Sponsor
- William Brandenburg, MD
- Study ID
- NCT07669168
- Status
- Recruiting
Conditions
- Activities of Daily Living
- Aging
- Cardiovascular Diseases
- Cognitive Dysfunction
- Frailty
- Health Behavior
- Health Equity
- Health Related Quality of Life
- Health Services Accessibility
- Medically Underserved Area
- Metabolic Syndrome
- Patient Participation
- Preventive Health Services
- Rural Health
- Telemedecine
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Interactive Personalized Health Report — BEHAVIORALStatic versus interactive health report
- Mobile Community-Based Health Screenings — BEHAVIORALMobile versus Fixed Laboratory Health Screenings
- Hybrid Medical Droid and Human Delivered Health Screenings — BEHAVIORALHybrid Medical Droid and Human Delivered versus Human-Only Delivered Health Screenings
Study Details
The Health Ahead Comparative Effectiveness Study is a pragmatic, parallel-arm interventional platform that systematically compares successive changes to preventive health screening - each isolated as a single variable against current practice - on the path toward a fully automated screening system deployable in any environment, including the most isolated and resource-limited communities. Each comparison is evaluated with a common set of engagement, behavior-change, experience, cost, and longitudinal outcome measures, allowing results to accumulate on a consistent yardstick across the life of the platform. The first comparison evaluates static versus interactive personalized health report delivery. Subsequent pre-planned comparisons, added by protocol amendment, evaluate mobile community versus fixed laboratory screening; and a hybrid medical-droid plus human-delivery model versus human-only screening. All participants are simultaneously enrolled in the 100-Year Human Aging Study and the Human Observatory Study, contributing individual longitudinal and population-level causal inference data through those protocols.
Key Dates
- Start date
- Jun 9, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2099
- Completion
- Dec 31, 2099
Study Design
- Enrollment
- 1,000,000 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Static Personalized Health ReportParticipants complete comprehensive multi-system health screening and receive a standard static personalized health report.
- Experimental: Interactive Personalized Health ReportParticipants complete identical comprehensive multi-system health screening and receive an interactive personalized report allowing real-time adjustment of behaviors and diagnostic inputs to visualize projected changes in composite scores, estimated biological age, and aging trajectory.
- Active Comparator: Fixed-Lab Health ScreeningsHealth screenings performed at fixed-lab site.
- Experimental: Mobile Lab Health ScreeningsHealth screenings performed in remote locations using a mobile lab
- Active Comparator: Human Delivered Health ScreeningsHealth screenings delivered by human operators only
- Experimental: Hybrid Medical Droid and Human Delivered Health ScreeningsHealth screenings delivered by a hybrid model using medical droid and human operators
Primary Outcome Measure
Health Activation and Engagement (Non-Inferiority) [ Time Frame: Baseline, 6-12-month follow-up, then periodically from enrollment until death, up to 100 years. ]
Central Contacts
- William Brandenburg, MD13035010016
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Longevity Metrics | Boulder | Colorado | 80301 |
Find similar trials in Boulder, CO
Related Studies
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Obesity, Metabolic Dysregulation and the Airway Epithelium in AsthmaticsRecruiting · University of Colorado, Denver · Aurora, Colorado
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older AdultsPHASE2 · Recruiting · Douglas Seals · Boulder, Colorado